Bioadaptives (BDPT) Payables (2013 - 2026)

Bioadaptives has disclosed Payables across 13 years of filings, most recently posting $673097.0 for Q1 2026.

• Payables for Q1 2026 came in at $673097.0, up 32.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $673097.0 (up 32.55% YoY), and the FY2025 annual result was $264821.0, down 58.65% from the prior year.
• Payables came in at $673097.0 for Q1 2026 at Bioadaptives, up from $264821.0 in the prior quarter.
• In the past five years, Payables ranged from a high of $831413.0 in Q2 2022 to a low of $236177.0 in Q2 2025.
• The 5-year median for Payables is $735423.0 (2023), against an average of $655931.2.
• Across the five-year window, Payables surged 560.37% in 2022 and plunged 69.3% in 2025, its largest moves.
• Bioadaptives' Payables stood at $791713.0 in 2022, then slipped by 3.34% to $765237.0 in 2023, then retreated by 16.31% to $640458.0 in 2024, then plunged by 58.65% to $264821.0 in 2025, then soared by 154.17% to $673097.0 in 2026.
• The last three Payables figures came in at $673097.0 (Q1 2026), $264821.0 (Q4 2025), and $590068.0 (Q3 2025), per Business Quant data.